Back to Brevan Howard Capital Management LP Brevan Howard Capital Management LP

TVTXTVTX

Showing 6 of 9 quarters

Position history for Brevan Howard Capital Management LPBrevan Howard Capital Management LP's holdings in Travere Therapeutics, Inc.

No. Brevan Howard Capital Management exited its TVTX (Travere Therapeutics) position in Q1 2026. Its Q4 2025 13F listed 29,067 shares worth $1.1M. Brevan Howard Capital Management first reported TVTX in Q4 2023 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$863,113

Total Shares Change

-61,695

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$29.71
0
2025-Q4
Decreased
29,067
-31.6%
$1.1M0.0%$38.21
0
2025-Q3
New
42,505
—
$1M0.0%$23.90
35
2025-Q1
Exited
0
-100.0%
$00.0%$17.92
0
2024-Q4
Decreased
30,953
-49.8%
$539,2010.0%$17.42
0
2024-Q3
Increased
61,695
+0.7%
$863,1130.0%$13.99
25

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used